R Clift

3.5k total citations
43 papers, 2.7k citations indexed

About

R Clift is a scholar working on Hematology, Oncology and Genetics. According to data from OpenAlex, R Clift has authored 43 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Hematology, 17 papers in Oncology and 10 papers in Genetics. Recurrent topics in R Clift's work include Hematopoietic Stem Cell Transplantation (31 papers), Acute Myeloid Leukemia Research (7 papers) and Neutropenia and Cancer Infections (7 papers). R Clift is often cited by papers focused on Hematopoietic Stem Cell Transplantation (31 papers), Acute Myeloid Leukemia Research (7 papers) and Neutropenia and Cancer Infections (7 papers). R Clift collaborates with scholars based in United States, South Africa and United Kingdom. R Clift's co-authors include CD Buckner, Jack W. Singer, F R Appelbaum, Rainer Storb, K Lilleby, H. Joachim Deeg, John A. Hansen, S Rowley, FR Appelbaum and Taner Demirer and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and Blood.

In The Last Decade

R Clift

43 papers receiving 2.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R Clift United States 23 1.9k 870 649 554 307 43 2.7k
Gerald J. Elfenbein United States 29 1.5k 0.8× 1.0k 1.2× 696 1.1× 356 0.6× 186 0.6× 97 3.2k
M Carotenuto Italy 26 1.1k 0.6× 680 0.8× 542 0.8× 609 1.1× 446 1.5× 81 2.2k
H. Kolb Germany 24 1.2k 0.6× 722 0.8× 508 0.8× 325 0.6× 220 0.7× 79 2.2k
JH Antin United States 24 1.8k 0.9× 566 0.7× 924 1.4× 383 0.7× 138 0.4× 50 2.8k
G.R. Morgenstern United Kingdom 26 1.1k 0.6× 917 1.1× 409 0.6× 300 0.5× 219 0.7× 50 2.6k
JA Hansen United States 30 3.4k 1.8× 778 0.9× 1.7k 2.6× 780 1.4× 142 0.5× 67 4.3k
Gabriel Cividalli Israel 22 3.6k 1.9× 1.1k 1.2× 1.6k 2.4× 1.0k 1.8× 226 0.7× 78 4.6k
Dagmar Oette United States 10 1.3k 0.7× 1.4k 1.6× 562 0.9× 185 0.3× 109 0.4× 13 2.6k
H. G. Prentice United Kingdom 32 1.3k 0.7× 681 0.8× 625 1.0× 283 0.5× 187 0.6× 63 2.7k
Agnès Devergie France 28 2.1k 1.1× 627 0.7× 800 1.2× 485 0.9× 96 0.3× 55 3.0k

Countries citing papers authored by R Clift

Since Specialization
Citations

This map shows the geographic impact of R Clift's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R Clift with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R Clift more than expected).

Fields of papers citing papers by R Clift

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R Clift. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R Clift. The network helps show where R Clift may publish in the future.

Co-authorship network of co-authors of R Clift

This figure shows the co-authorship network connecting the top 25 collaborators of R Clift. A scholar is included among the top collaborators of R Clift based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R Clift. R Clift is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Franklin, Mark A., et al.. (2002). Characterization of microbial populations and volatile fatty acid concentrations in the jejunum, ileum, and cecum of pigs weaned at 17 vs 24 days of age. Journal of Animal Science. 80(11). 2904–2910. 121 indexed citations
2.
Lucarelli, Giuseppe, R Clift, M Galimberti, et al.. (1999). Bone Marrow Transplantation in Adult Thalassemic Patients. Blood. 93(4). 1164–1167. 11 indexed citations
3.
Demirer, Taner, CD Buckner, B. Storer, et al.. (1997). Effect of different chemotherapy regimens on peripheral-blood stem-cell collections in patients with breast cancer receiving granulocyte colony-stimulating factor.. Journal of Clinical Oncology. 15(2). 684–690. 58 indexed citations
4.
Schiffman, K, CD Buckner, Richard T. Maziarz, et al.. (1997). High-dose busulfan, melphalan, and thiotepa followed by autologous peripheral blood stem cell transplantation in patients with aggressive lymphoma or relapsed Hodgkin's disease.. PubMed. 3(5). 261–6. 22 indexed citations
5.
Huss, Ralf, H. Joachim Deeg, Ted Gooley, et al.. (1996). Effect of mixed chimerism on graft-versus-host disease, disease recurrence and survival after HLA-identical marrow transplantation for aplastic anemia or chronic myelogenous leukemia.. PubMed. 18(4). 767–76. 78 indexed citations
6.
Demirer, Taner, Charles H. Weaver, CD Buckner, et al.. (1995). High-dose cyclophosphamide, carmustine, and etoposide followed by allogeneic bone marrow transplantation in patients with lymphoid malignancies who had received prior dose-limiting radiation therapy.. Journal of Clinical Oncology. 13(3). 596–602. 71 indexed citations
7.
Clift, R, CD Buckner, Claudio Anasetti, et al.. (1994). Allogeneic marrow transplantation for chronic myeloid leukemia. Medical Oncology. 11(2). 69–74. 9 indexed citations
8.
9.
Petersen, F. Bonde, M. Lynch, R Clift, et al.. (1993). Autologous marrow transplantation for patients with acute myeloid leukemia in untreated first relapse or in second complete remission.. Journal of Clinical Oncology. 11(7). 1353–1360. 43 indexed citations
10.
Singer, Jack W., CD Buckner, R Clift, et al.. (1992). Phase I study of busulfan and cyclophosphamide in preparation for allogeneic marrow transplant for patients with multiple myeloma.. Journal of Clinical Oncology. 10(9). 1492–1497. 45 indexed citations
11.
12.
Singer, Jack W., Petersen Fb, M Banaji, et al.. (1989). Engraftment and transfusion requirements after allogeneic marrow transplantation for patients with acute non-lymphocytic leukemia in first complete remission.. PubMed. 4(4). 409–14. 13 indexed citations
13.
Storb, Rainer, H. Joachim Deeg, L Fisher, et al.. (1988). Cyclosporine v methotrexate for graft-v-host disease prevention in patients given marrow grafts for leukemia: long-term follow-up of three controlled trials. Blood. 71(2). 293–298. 6 indexed citations
14.
Appelbaum, F R, Keith M. Sullivan, CD Buckner, et al.. (1987). Treatment of malignant lymphoma in 100 patients with chemotherapy, total body irradiation, and marrow transplantation.. Journal of Clinical Oncology. 5(9). 1340–1347. 207 indexed citations
15.
Singer, Jack W., et al.. (1983). The effect of blood cooling prior to granulocyte collection. Transfusion. 23(4). 342–343. 2 indexed citations
16.
Storb, Rainer, M Banaji, CD Buckner, et al.. (1983). Transfusion Requirements after HLA‐Identical Marrow Transplantation in 82 Patients with Aplastic Anemia. Vox Sanguinis. 44(6). 366–374. 15 indexed citations
17.
Buckner, CD, F L Johnson, E. Donnall Thomas, et al.. (1973). Allogeneic marrow grafting in acute lymphoid leukemia during marrow remission.. PubMed. 18(4). 295–303. 5 indexed citations
18.
Clifford, Peter, et al.. (1964). Dimethyl Myleran Therapy Combined with Abdominal Aortic Occlusion. British Journal of Cancer. 18(3). 435–448. 7 indexed citations
19.
Clifford, Peter, et al.. (1963). Oral Melphalan Therapy in Advanced Malignant Disease. British Journal of Cancer. 17(3). 381–390. 11 indexed citations
20.
Clifford, Peter, et al.. (1961). NITROGEN-MUSTARD THERAPY COMBINED WITH AUTOLOGOUS MARROW INFUSION. The Lancet. 277(7179). 687–690. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gerald J. Elfenbein Breakdown of academic impact, for papers by M Carotenuto Breakdown of academic impact, for papers by H. Kolb Breakdown of academic impact, for papers by JH Antin Breakdown of academic impact, for papers by G.R. Morgenstern Breakdown of academic impact, for papers by JA Hansen Breakdown of academic impact, for papers by Gabriel Cividalli Breakdown of academic impact, for papers by Dagmar Oette Breakdown of academic impact, for papers by H. G. Prentice Breakdown of academic impact, for papers by Agnès Devergie
Rankless by CCL
2026